Adenocarcinoma, Scirrhous  >>  dovitinib (TKI258)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dovitinib (TKI258) / Allarity Therap, Oncoheroes
NCT01576380: A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients

Completed
2
11
Japan
TKI258, Dovitinib
Novartis Pharmaceuticals
Adenocarcinoma, Scirrhous, Linitis Plastica, Stomach Neoplasms, Stomach Diseases, Neoplasms by Site, Neoplasms
09/13
09/13

Download Options